Results 111 to 120 of about 21,823 (309)

Transjugular intrahepatic portosystemic shunt: Where are we?

The Turkish Journal of Gastroenterology, 2014
The purpose of this study was to evaluate the technical/hemodynamic success, complications, and biochemical/ hematologic consequences of transjugular intrahepatic portosystemic shunt (TIPS) created with 10-mm bare stents in our patients.Data of 27 cirrhotic patients (18 men and 9 women; mean age, 39.7±18.7 years) with a median MELD score 14 (range 7-31)
Serkan Ocal, Murat Kormaz, Ali Harman, Reskan Altun, Haldun Selçuk, Enver Akbaş, Emre Yıldırım   +6 more
openaire   +3 more sources

Portal vein velocity and its dynamics: a potentially useful tool for detecting clinically silent transjugular intrahepatic porto-systemic shunt dysfunction using Doppler ultrasonography

Ultrasound International Open
Background  Ultrasound (US) surveillance for transjugular intrahepatic portosystemic shunt (TIPS) dysfunction has yet to be standardized, as clear-cut criteria have not been conventionally defined.
Rareș Crăciun, Horia Ștefănescu, Oana Nicoară-Farcău, Petra Fischer, Andreea Fodor, Marcel Tanţău, Corina Radu, Zeno Spârchez, Bogdan Procopeţ   +8 more
doaj   +1 more source

Refractory Ascites in Patients With Cirrhosis

JGH Open, Volume 9, Issue 8, August 2025.
Madhumita Premkumar
wiley   +1 more source

Direct Intrahepatic Portosystemic Shunt in Budd-Chiari Syndrome: A Case Report and Review of the Literature

Case Reports in Radiology, 2018
Transjugular intrahepatic portosystemic shunt (TIPS) is an alternative interventional procedure used to manage refractory Budd-Chiari syndrome (BCS) when conservative medical therapy has failed.
V. Chandra, E. Wajswol, M. Shahid, A. Kumar, S. Contractor   +4 more
doaj   +1 more source

Parallel Transjugular Intrahepatic Portosystemic Shunt with Viatorr\u3csup\u3e®\u3c/sup\u3e Stents for Primary TIPS Insufficiency: Case Series and Review of Literature [PDF]

, 2019
BACKGROUND Transjugular intrahepatic portosystemic shunts (TIPS) can alleviate complications of portal hypertension such as ascites and variceal bleeding by decreasing the portosystemic gradient.
Krohmer, Steven, Nisiewicz, Michael, Raissi, Driss, Yu, Qian   +3 more
core   +1 more source

The role of transjugular intrahepatic portosystemic shunt in patients with cirrhosis and ascites: Recent evolution and open questions

, 2022
P. Deltenre, A. Zanetto, D. Saltini, Christophe Moreno, F. Schepis   +4 more
semanticscholar   +1 more source

A successful endovascular repositioning of migrated transjugular intrahepatic portosystemic shunt (TIPS) stent

Radiology Case Reports, 2021
The transjugular intrahepatic portosystemic shunt (TIPS) procedure is performed to create an intrahepatic tract between the hepatic and portal veins which helps to shunt blood away from the hepatic sinusoids.
Kavya Mirchia, MD, Ryan Thibodeau, MPH, Atin Goel, MBBS, Abtin Jafroodifar, MD, Ivan Babin, MD, Zhongxia Hu, MD, Zachary Love, NP, Sanjit Tewari, MD, Mohammed Jawed, MD   +8 more
doaj  

Pneumatic dilation for achalasia in a patient with esophageal varices

Endoscopy International Open, 2016
Background and study aims: Previous reports of simultaneous presence of esophageal varices (EV) and achalasia suggest placement of a transjugular intrahepatic portosystemic shunt (TIPS) and surgical myotomy or endoscopic therapy.
Etienne Désilets, Arthur Belle, Christian Boustière, Arthur Laquière   +3 more
doaj   +1 more source

Pancreatic Panniculitis Without Pancreatopathy: A Rare Complication of Splenic Vein Stenting for Portal Hypertension in Myeloproliferative Syndrome

United European Gastroenterology Journal, Volume 13, Issue 6, Page 1031-1032, July 2025.
Eliza Butnaru, Solène Tran Van, Franck Brazier, Clara Yzet   +3 more
wiley   +1 more source

Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve. [PDF]

, 2019
Purpose: To determine whether chemoembolization using drug-eluting beads (DEB-TACE) is safe and effective for liver transplantation candidates with liver-limited hepatocellular carcinoma (HCC) without vascular invasion and baseline hepatic dysfunction ...
Fidelman, Nicholas, Johanson, Curt, Kelley, R Kate, Kerlan, Robert K, Kohi, Maureen P, Kohlbrenner, Ryan M, Kolli, K Pallav, Lehrman, Evan D, Roberts, John P, Taylor, Andrew G, Yao, Francis Y   +10 more
core   +1 more source